$0.01 EPS Expected for Hamilton Thorne Ltd (HTL)

August 22, 2017 – By Nellie Frank

Investors wait Hamilton Thorne Ltd (CVE:HTL) to report on August, 23. its quarterly earnings This translates into $1.07M profit for V_HTL giving the stock a 18.75 P/E. This is assuming the current $0.01 EPS is accurate. The stock decreased 5.06% or $0.04 on August 21, reaching $0.75. About 178,602 shares traded or 472.35% up from the average. Hamilton Thorne Ltd (CVE:HTL) has 0.00% since August 22, 2016 and is . It has underperformed by 16.70% the S&P500.

Hamilton Thorne Ltd. is engaged in the development, manufacture and sale of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets. The company has market cap of $80.02 million. The Firm offers Clinical lasers, Research lasers and Clinical Sperm Analysis Products. It has a 99.21 P/E ratio. The Company’s Clinical lasers include LYKOS laser and ZILOS-tk laser for applications, such as laser-assisted hatching and embryo biopsy for pre-implantation genetic diagnosis .

More notable recent Hamilton Thorne Ltd (CVE:HTL) news were published by: Marketwired.com which released: “Hamilton Thorne Announces the Acquisition of Embryotech Laboratories” on September 16, 2016, also Marketwired.com with their article: “Hamilton Thorne Launches New Dimensions II Strict Morphology Software for the …” published on October 14, 2013, Globenewswire.com published: “Hamilton Thorne to announce Q2 2017 financial results and Host conference call …” on August 16, 2017. More interesting news about Hamilton Thorne Ltd (CVE:HTL) were released by: Marketwatch.com and their article: “0.6723” published on May 25, 2011 as well as Prnewswire.com‘s news article titled: “Merck KGaA, Darmstadt, Germany, Welcomes ZEISS and Hamilton Thorne as New …” with publication date: June 30, 2016.